TMEM106B and Alzheimer disease: For example, by using brain endophenotypes, researchers have identified novel protective genetic variants in TMEM106B and MS4A genes, associated with neuroprotection (high neuronal proportion) in AD [28], and increased CSF soluble triggering receptor expressed on myeloid cells 2 (sTREM2) concentrations with reduced AD risk, respectively [29].